TrialJournal of child neurology2021

A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.

John M Schreiber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.